Thus, along with the recent report showing effects of memantine on cued memory retrieval and the N400 ERP repetition effect19, our studies support the hypothesis that memantine might reduce FMR1 premutation-associated abnormalities in glutamatergic signalling and improve cognition in patients with FXTAS. This evidence concerns the gene FMR1 and fragile X-associated tremor/ataxia syndrome.